Literature DB >> 20969907

Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.

Lixin Wang1, Andreas Stengel, Miriam Goebel, Vicente Martinez, Guillaume Gourcerol, Jean Rivier, Yvette Taché.   

Abstract

The orexigenic effect of urocortins (Ucns), namely Ucn 1, Ucn 2 and Ucn 3 through activation of corticotropin-releasing factor (CRF) receptors, has been well characterized after injection into the brain but not in the periphery. We examined the role of CRF receptor subtype 2 (CRF(2)) in the regulation of food intake using intraperitoneal (ip) injection of Ucns and the selective CRF(2) antagonist, astressin(2)-B, and CRF(2) knockout (-/-) mice. Meal structures were monitored using an automated episodic solid food intake monitoring system. Ucn 2 (3, 10 or 30 μg/kg, ip) induced a rapid in onset, long lasting and dose-dependent decrease (38%, 66% and 86%, respectively at 4h) of cumulative food intake after an overnight fast in mice. Ucn 3 anorexic effect was 10-times less potent. Astressin(2)-B (30 or 100 μg/kg) injected ip, but not intracerebroventricularly, blocked the inhibitory effect of ip Ucn 1 and Ucn 2 (10 μg/kg). Fasted CRF(2-/-) mice did not respond to ip Ucn 1 (10 μg/kg). Meal microstructure analysis of the 4-h re-feeding response to an overnight fast showed that Ucn 2 (10 μg/kg, ip) decreased meal size and duration, but increased meal frequency. In mice fed ad libitum, Ucn 2 (30 μg/kg) injected ip before the dark phase decreased the 4-h nocturnal meal size and duration without influencing meal frequency while the 10 μg/kg dose had no effect. These data indicate that Ucns, through peripheral CRF(2) receptor-mediated induction of satiation, inhibit the eating response to a fast more potently than the physiological nocturnal feeding in mice.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20969907      PMCID: PMC3010521          DOI: 10.1016/j.peptides.2010.10.017

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  42 in total

1.  Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.

Authors:  L Wang; V Martínez; J E Rivier; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

2.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

4.  Urocortin, corticotropin releasing factor-2 receptors and energy balance.

Authors:  M J Cullen; N Ling; A C Foster; M A Pelleymounter
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

5.  Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.

Authors:  Vicente Martínez; Lixin Wang; Jean E Rivier; Wylie Vale; Yvette Taché
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

6.  Diurnal rhythm of agouti-related protein and its relation to corticosterone and food intake.

Authors:  Xin-Yun Lu; Kun-Ruey Shieh; Mohamed Kabbaj; Gregory S Barsh; Huda Akil; Stanley J Watson
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

7.  Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat.

Authors:  Koki Inoue; Glenn R Valdez; Teresa M Reyes; Lindsay E Reinhardt; Antoine Tabarin; Jean Rivier; Wylie W Vale; Paul E Sawchenko; George F Koob; Eric P Zorrilla
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

8.  The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.

Authors:  A J Lawrence; E V Krstew; F M Dautzenberg; A Rühmann
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.

Authors:  J Rivier; J Gulyas; D Kirby; W Low; M H Perrin; K Kunitake; M DiGruccio; J Vaughan; J C Reubi; B Waser; S C Koerber; V Martinez; L Wang; Y Taché; W Vale
Journal:  J Med Chem       Date:  2002-10-10       Impact factor: 7.446

10.  Differential interactions of urocortin/corticotropin-releasing hormone peptides with the blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom
Journal:  Neuroendocrinology       Date:  2002-06       Impact factor: 4.914

View more
  14 in total

1.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

2.  Effect of Urocortin on strength and microarchitecture of osteopenic rat femur.

Authors:  Mohammad Tezval; Silja Hansen; Ulrich Schmelz; Marina Komrakova; Klaus Michael Stuermer; Stephan Sehmisch
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

3.  Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.

Authors:  Miriam Goebel-Stengel; Andreas Stengel; Lixin Wang; Yvette Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-11       Impact factor: 3.619

4.  Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.

Authors:  Pu-Qing Yuan; S Vincent Wu; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

5.  Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.

Authors:  Lixin Wang; Andreas Stengel; Miriam Goebel-Stengel; Almaas Shaikh; Pu-Qing Yuan; Yvette Taché
Journal:  Peptides       Date:  2012-11-23       Impact factor: 3.750

6.  The cytokine ciliary neurotrophic factor (CNTF) activates hypothalamic urocortin-expressing neurons both in vitro and in vivo.

Authors:  Matthew J Purser; Prasad S Dalvi; Zi C Wang; Denise D Belsham
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  Patterns of Brain Activation and Meal Reduction Induced by Abdominal Surgery in Mice and Modulation by Rikkunshito.

Authors:  Lixin Wang; Sachiko Mogami; Seiichi Yakabi; Hiroshi Karasawa; Chihiro Yamada; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 8.  CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2014-03-18       Impact factor: 4.677

9.  Actions of Agonists and Antagonists of the ghrelin/GHS-R Pathway on GH Secretion, Appetite, and cFos Activity.

Authors:  Rim Hassouna; Alexandra Labarthe; Philippe Zizzari; Catherine Videau; Michael Culler; Jacques Epelbaum; Virginie Tolle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

10.  A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice.

Authors:  Rim Hassouna; Philippe Zizzari; Odile Viltart; Seung-Kwon Yang; Robert Gardette; Catherine Videau; Emilio Badoer; Jacques Epelbaum; Virginie Tolle
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.